2023
DOI: 10.3389/fbinf.2023.1069487
|View full text |Cite
|
Sign up to set email alerts
|

Joint visualization of seasonal influenza serology and phylogeny to inform vaccine composition

Abstract: Seasonal influenza vaccines must be updated regularly to account for mutations that allow influenza viruses to escape our existing immunity. A successful vaccine should represent the genetic diversity of recently circulating viruses and induce antibodies that effectively prevent infection by those recent viruses. Thus, linking the genetic composition of circulating viruses and the serological experimental results measuring antibody efficacy is crucial to the vaccine design decision. Historically, genetic and s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 35 publications
0
1
0
Order By: Relevance
“…It is well known that influenza vaccine effectiveness is highly dependent on the matching of strains in influenza vaccines and actually circulating viruses [ 22 ]. In recent years, many tools have been proposed to contribute to the vaccine selection process including short-term modeling strategies and visualizations [ 4 , 23 , 24 ] but none of them currently can predict the vaccine strains without ongoing global surveillance activities and massive antigenic and genetic analysis work conducted by the WHO CCs and the NICs [ 25 ].…”
Section: Discussionmentioning
confidence: 99%
“…It is well known that influenza vaccine effectiveness is highly dependent on the matching of strains in influenza vaccines and actually circulating viruses [ 22 ]. In recent years, many tools have been proposed to contribute to the vaccine selection process including short-term modeling strategies and visualizations [ 4 , 23 , 24 ] but none of them currently can predict the vaccine strains without ongoing global surveillance activities and massive antigenic and genetic analysis work conducted by the WHO CCs and the NICs [ 25 ].…”
Section: Discussionmentioning
confidence: 99%